Since 1998, she has been involved in the theoretical and commercial development of technological platforms for measurement and automation in various industries, including climate monitoring and biotechnology.

[1][3][4] In the United States, Barbara Paldus has built several biotech companies from scratch, whose instruments and technologies were utilized in large-scale vaccine production during the Ebola and COVID-19 pandemics.

[5] Before emigrating, her mother was a dentist in Prague and her father[10][11] worked as a research scientist at the Institute of Physical Chemistry of the Czechoslovak Academy of Sciences.

[11] Paldus received the Adolph Lomb Medal in 2001 for her contributions to cavity spectroscopy, a sensitive absolute method for trace gas analysis.

"[7] The fund supports companies led by women or diverse founders, developing scientifically validated health and wellness products, including dermo-cosmetics.

[5][19] Since 2018, Paldus has also been the founder and CEO of Codex Labs,[1] a biotech company collaborating with technologists, chemists, biologists, dermatologists, and ethnobotanists.